December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProShares UltraPro Russell2000 (NY:URTY)

59.49 -0.17 (-0.28%)
Streaming Delayed Price Updated: 11:54 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProShares UltraPro Russell2000

Rumble Rallies After Unveiling Tether-Powered Crypto Wallet – Retail Expects Stock To Surpass The $10 Mark ↗
Via Stocktwits
Zeta Global Shares Rose After It Deepens Collaboration with OpenAI ↗
Via Stocktwits
News headline image
Why Did Ironwood Pharmaceuticals Stock Skyrocket Today? ↗
The company announced on Friday that it expects FY2026 revenue in the $450 million to $475 million range. 
Via Stocktwits
News headline image
Verastem Oncology Stock Drops After Hours After Discontinuing A Clinical Trial In Lung Cancer ↗
The company discontinued its trial in advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC) following evaluation of interim data. 
Via Stocktwits
Topics Supply Chain
MannKind Stock Soared 8% Today: Why A Surge In Afrezza Inhaled Insulin Sales Matters ↗
Via Stocktwits
Ardelyx Shares Soar Premarket As CEO Sees Continued Demand For Blockbuster Drug Ibsrela ↗
Via Stocktwits
Why Is SELLAS Life Sciences Stock Falling Today? ↗
Via Stocktwits
KURA Stock Rises Pre-Market After Receiving Milestone Payment Related To Cancer Drug Development Agreement ↗
Via Stocktwits
Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors? ↗
Via Stocktwits
TrueCar Shares Soar Following $227M Go-Private Deal ↗
Via Stocktwits
News headline image
Why Did NTLA Stock Tumble 43% Pre-Market Today? ↗
Intellia said that it has temporarily paused patient dosing and screening for two of its late-stage trials for Nex-z. 
Via Stocktwits
Candel Therapeutics Enters $130M Term Loan Facility To Advance Lead Product Candidate In Treatment Of Lung Cancer ↗
Via Stocktwits
Esperion Shares Rally After Patent Litigation Settlement For Cholesterol Drugs ↗
Via Stocktwits
Topics Intellectual Property
Larimar Therapeutics Stock Slumps Pre-market Over High Anaphylaxis Rate In Drug Study ↗
Via Stocktwits
News headline image
X4 Pharmaceuticals Stock Rises On Closing Of Upsized Offering, But Brokerage Lowers Price Target ↗
The company said that the originally announced offering of $60 million was increased to $85 million to allow for the inclusion of an investor who had a pre-existing investment right. 
Via Stocktwits
Topics Economy
News headline image
5 Best Leveraged ETFs of Last Week ↗
The S&P 500 hit a record close last week, courtesy of a Santa Clause rally. Wall Street was charged-up with the S&P 500 (up 1.22%), the Dow Jones (up 0.15%), the Nasdaq Composite (up 3.12%) and the... 
Via Talk Markets
News headline image
Analyzing ProShares UltraPro Russell2000's Unusual Options Activity ↗
On Monday, shares of ProShares UltraPro Russell2000 (NYSE:URTY) saw unusual options activity. After the option alert, the stock price moved down to $98.51. Sentiment: BEARISH... 
Via Benzinga
News headline image
Global Markets Start The Week Very Volatile – Metals & Oil Collapse, Part II ↗
A look at how Precious Metals, the US Dollar, and the US major markets have moved into a sideways price trend which supports a pending future volatility event. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.